Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Yzer

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
The British Journal of Ophthalmology|July 14, 2018
Discrepancy in current central serous chorioretinopathy classificationSumit Randhir Singh, Alexandre Matet, Elon H C van Dijk, et al.
Retina (Philadelphia, Pa.)|December 1, 2017
FAMILIAL CENTRAL SEROUS CHORIORETINOPATHYElon H C van Dijk, Rosa L Schellevis, Myrte B Breukink, et al.
Ophthalmology Science|June 19, 2023
Evaluation of Sleep Quality and Fatigue in Patients with Usher Syndrome Type 2aJessie M Hendricks, Juriaan R Metz, Hedwig M Velde, et al.
American Journal of Ophthalmology|March 18, 2026
Long-term follow-up of PLACE and SPECTRA trials: outcomes after successful and unsuccessful half-dose photodynamic therapy for chronic central serous chorioretinopathyFemke M van den Tillaart, Jennifer M Chang-Wolf, Helena M A Feenstra, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 23, 2026
From Sound to Stability: Lessons Learned From the CRUSH Study on Hearing Loss Progression and Vestibular Phenotype in Usher Syndrome Type 2ADirk H Wijn, Mirthe L A Fehrmann, Sybren M M Robijn, et al.
Ophthalmology and Therapy|May 16, 2024
Perspectives and Update on the Global Shortage of Verteporfin (Visudyne<sup>®</sup>)Marc J Sirks, Yousif Subhi, Noa Rosenberg, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHYHelena M A Feenstra, Roselie M H Diederen, Martine J C M Lamme, et al.
American Journal of Human Genetics|August 16, 2006
Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosisAnneke I den Hollander, Robert K Koenekoop, Suzanne Yzer, et al.
Human Mutation|March 26, 2014
Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathyCarl Schubert, Anders Pryds, Shemin Zeng, et al.
Human Genetics|February 28, 2022
Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variantsHedwig M Velde, Janine Reurink, Sebastian Held, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
The British Journal of Ophthalmology|July 14, 2018
Discrepancy in current central serous chorioretinopathy classificationSumit Randhir Singh, Alexandre Matet, Elon H C van Dijk, et al.
Retina (Philadelphia, Pa.)|December 1, 2017
FAMILIAL CENTRAL SEROUS CHORIORETINOPATHYElon H C van Dijk, Rosa L Schellevis, Myrte B Breukink, et al.
Ophthalmology Science|June 19, 2023
Evaluation of Sleep Quality and Fatigue in Patients with Usher Syndrome Type 2aJessie M Hendricks, Juriaan R Metz, Hedwig M Velde, et al.
American Journal of Ophthalmology|March 18, 2026
Long-term follow-up of PLACE and SPECTRA trials: outcomes after successful and unsuccessful half-dose photodynamic therapy for chronic central serous chorioretinopathyFemke M van den Tillaart, Jennifer M Chang-Wolf, Helena M A Feenstra, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 23, 2026
From Sound to Stability: Lessons Learned From the CRUSH Study on Hearing Loss Progression and Vestibular Phenotype in Usher Syndrome Type 2ADirk H Wijn, Mirthe L A Fehrmann, Sybren M M Robijn, et al.
Ophthalmology and Therapy|May 16, 2024
Perspectives and Update on the Global Shortage of Verteporfin (Visudyne<sup>®</sup>)Marc J Sirks, Yousif Subhi, Noa Rosenberg, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHYHelena M A Feenstra, Roselie M H Diederen, Martine J C M Lamme, et al.
American Journal of Human Genetics|August 16, 2006
Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosisAnneke I den Hollander, Robert K Koenekoop, Suzanne Yzer, et al.
Human Mutation|March 26, 2014
Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathyCarl Schubert, Anders Pryds, Shemin Zeng, et al.
Human Genetics|February 28, 2022
Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variantsHedwig M Velde, Janine Reurink, Sebastian Held, et al.
Pageof 8